List/Grid

Helus Pharma Nomeia Michael Cola como Diretor Executivo para Liderar a Próxima Fase de Escala e Execução

  • Ex-presidente da empresa farmacêutica especializada da Shire PLC ("Shire"), com mais de 30 anos de experiência em neurociência, doenças raras e produtos farmacêuticos... More >>

Bitget e BlockSec Lançam UEX Security Standard, Definindo um Novo Benchmark para Universal Exchanges

VICTORIA, Seychelles, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bitget, a... More >>

Bitget et BlockSec présentent la norme de sécurité UEX, établissant une nouvelle référence pour les bourses universelles

VICTORIA, Seychelles, 11 févr. 2026 (GLOBE NEWSWIRE) -- More >>

Hatch selected by Maaden as partner to accelerate mining development in Saudi Arabia

RIYADH, Saudi Arabia, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Hatch, a global leader in engineering, project delivery, and professional services, has been selected by Maaden (Saudi Arabian Mining Company) as its strategic delivery partner across a number of strategic... More >>

معادن تختار شركة هاتش العالمية للاستشارات الهندسية (Hatch) كشريك لتسريع تطوير قطاع التعدين في المملكة العربية السعودية

الرياض، المملكة العربية السعودية, Feb. 11, 2026 (GLOBE NEWSWIRE) -- More >>

Les feux d’artifice de Liuyang illuminent le ciel nocturne d’Abou Dabi

LIUYANG, Chine, 10 févr. 2026 (GLOBE NEWSWIRE) -- Le soir du 6 février, heure locale, des feux d’artifice de Liuyang ont illuminé le ciel nocturne d’Abou Dabi, capitale des Émirats arabes unis (EAU), lors d’un spectacle... More >>

AlphaTON Capital at Consensus Hong Kong: Unveiling the Confidential AI Infrastructure for 1 Billion Users

HONG KONG, Feb. 10, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON), the world's leading public technology company scaling the Telegram super app for an addressable market of over 1 billion monthly active users, today announced... More >>

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

  • Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and... More >>